COMMUNIQUÉS West-GlobeNewswire

MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary Market
09/06/2025
IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc ., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology , LLC , a wholly-owned subsidiary [...]
Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025
09/06/2025
Presentation to be webcast live at 10:00 AM ET NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging [...]
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
09/06/2025
Los Angeles, CA & Vancouver, BC, June 09, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May [...]
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
09/06/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a [...]
Medicovestor, Inc. and Sanyou Biopharmaceuticals Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates
09/06/2025
NEW YORK and SHANGHAI, June 09, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a New York-based biotechnology company pioneering first-in-class chemoimmunotherapy antibody-drug conjugates (ADCs) today announced a [...]
Micron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors
09/06/2025
Role will focus on helping to inform and build public trust in vaccine and therapy options that are delivered without injections, through dissolvable technology ATLANTA, June 09, 2025 (GLOBE NEWSWIRE) -- Micron [...]
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
09/06/2025
MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Circuit Clinical Solutions Inc. [“Circuit Clinical”] and Lightship Inc. [“Lightship”] Announce Strategic Merger to Accelerate Scale and Expanded Access in Clinical Research
09/06/2025
BUFFALO, N.Y. and MORRISVILLE, N.C., June 09, 2025 (GLOBE NEWSWIRE) -- Today, Lightship and Circuit Clinical proudly announce their strategic merger, forming a leading, unified force in clinical trial delivery. This [...]
Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
09/06/2025
Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized dosing and therapeutic support for patients with conditions like Parkinson's and multiple sclerosis [...]
MD Anderson and HealthEx Announce Collaboration to Develop New Platform to Give Patients Direct Control of Data Access
09/06/2025
Platform aims to simplify and improve patient consent process to strengthen future initiatives HOUSTON and SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and HealthEx [...]
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
09/06/2025
R&D and cross-functional operations will be centralized in a single location to enhance collaboration and operational efficiency. Tevogen.AI, strengthened by its partnership with Microsoft, continues to expand. An [...]
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
09/06/2025
VALENCIA, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today highlighted data presented by [...]
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
09/06/2025
National TV Segment Highlights FDA-Approved Treatment for Rosacea Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET SCOTTSDALE, Ariz., June 09, 2025 (GLOBE NEWSWIRE [...]
FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer
09/06/2025
Seasoned finance executive brings over 20 years of public company and capital markets experience to support clinical-stage growth HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“ [...]
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
09/06/2025
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the [...]
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
09/06/2025
The addition of the head of Sales Operations & Analytics aims to strengthen sales infrastructure and launch execution HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer [...]
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital
09/06/2025
SUH is the Largest Hospital in Sweden and a Highly Influential Center for VT in Scandinavia FORT MILL, S.C., June 09, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device [...]
De nouvelles analyses confirment les avantages à long terme de la quadrithérapie DARZALEX® (daratumumab) par voie sous-cutanée chez les patients atteints d’un myélome multiple nouvellement diagnostiqué
09/06/2025
Les taux de négativité soutenue de la MRM (10 -5 ) à 24 mois ou plus ont plus que doublé chez les patients éligibles à une greffe traités par daratumumab-VRd par rapport au VRd seul dans l’étude de Phase 3 PERSEUS 1 Les [...]
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
09/06/2025
Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline includes first-in [...]

Pages